U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Hematologic Malignancy

MedGen UID:
233401
•Concept ID:
C1335737
•
Neoplastic Process
Synonyms: Recurrent Hematologic Cancer; Recurrent Hematopoietic and Lymphoid Cell Neoplasm; Relapsed Hematologic Cancer; Relapsed Hematologic Malignancy

Definition

The reemergence of a hematologic malignancy after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Hematologic Malignancy

Professional guidelines

PubMed

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation.
Collins RH Jr, Pineiro LA, Nemunaitis JJ, Jain VK, Waxman D, Miller WV, Fay JW
Transfusion 1995 Nov-Dec;35(11):891-8. doi: 10.1046/j.1537-2995.1995.351196110891.x. PMID: 8604484

Recent clinical studies

Etiology

Cellular immunotherapy after allogeneic stem cell transplantation in hematologic malignancies.
Kolb HJ, Simoes B, Schmid C
Curr Opin Oncol 2004 Mar;16(2):167-73. doi: 10.1097/00001622-200403000-00015. PMID: 15075911

Diagnosis

Disseminated cytomegalovirus infection with bilateral adrenal pseudotumors masquerading as recurrent hematologic malignancy.
Cabrera NL, Malek AE, Shelburne S, Taremi M, Awadh H, Francisco D, Robins A, Jabbour E, Chemaly RF
Infection 2020 Jun;48(3):477-481. Epub 2020 Mar 6 doi: 10.1007/s15010-020-01404-9. PMID: 32144592
Leukemic infiltration presenting as myocardial hypertrophy after complete remission of acute myeloid leukemia.
Jung MH, Lee YH, Lee KY, Jung HO, Youn HJ
Echocardiography 2017 Jan;34(1):136-138. Epub 2016 Oct 25 doi: 10.1111/echo.13404. PMID: 27779355

Therapy

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation.
Collins RH Jr, Pineiro LA, Nemunaitis JJ, Jain VK, Waxman D, Miller WV, Fay JW
Transfusion 1995 Nov-Dec;35(11):891-8. doi: 10.1046/j.1537-2995.1995.351196110891.x. PMID: 8604484

Prognosis

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation.
Collins RH Jr, Pineiro LA, Nemunaitis JJ, Jain VK, Waxman D, Miller WV, Fay JW
Transfusion 1995 Nov-Dec;35(11):891-8. doi: 10.1046/j.1537-2995.1995.351196110891.x. PMID: 8604484
Development of a single probe for documentation of chimerism following bone marrow transplantation.
Yam P, Petz LD, Ali S, Stock AD, Wallace RB
Am J Hum Genet 1987 Nov;41(5):867-81. PMID: 2890295Free PMC Article

Clinical prediction guides

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation.
Collins RH Jr, Pineiro LA, Nemunaitis JJ, Jain VK, Waxman D, Miller WV, Fay JW
Transfusion 1995 Nov-Dec;35(11):891-8. doi: 10.1046/j.1537-2995.1995.351196110891.x. PMID: 8604484

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...